The S&P/ASX 200 Index (ASX: XJO) is having a reasonably positive start to the week. In afternoon trade, the benchmark index is up 0.35% to 7,100 points.
Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping:
Imugene Limited (ASX: IMU)
The Imugene share price has continued its slide and is down a further 6% to 16.5 cents. This means that the biotech company’s shares are now down over 60% since the start of the year. Valuation concerns have been weighing on its shares. There may also be fears that this trend could continue given its market capitalisation of almost $1 billion and no revenue.
Integrated Research Limited (ASX: IRI)
The Integrated Research share price has sunk 15% to 57.5 cents. This morning the global provider of user experience and performance management solutions revealed that trading conditions have been tough. As a result, it no longer expects to deliver profit growth in FY 2022.
Monash IVF Group Ltd (ASX: MVF)
The Monash IVF share price is down a further 5% to $1.01. This fertility treatment company’s shares have now fallen 14% since the release of a disappointing trading update last week. That update revealed that the current environment has negatively impacted stimulated cycle activity and profitability between January to April as patients defer treatment.
Step One Clothing Ltd (ASX: STP)
The Step One share price has crashed 55% to 21.5 cents. Investors have been selling this underwear retailer’s shares after it revealed that its expansion into the UK, US, and women’s markets hasn’t gone to plan. As a result, it expects to fall well short of its earnings guidance in FY 2022. This appears to have led to investors doubting that Step One has what it takes to successfully expand outside Australia. The company’s shares are now down 86% from its November IPO price of $1.53.
The post Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- ASX 200 midday update: Brambles rockets, Goodman upgrades guidance
- Why is the Step One share price crashing 54% to a new low?
- Why A2 Milk, Gold Road, GrainCorp, and Monash IVF shares are dropping
- Why Block, IDP Education, Monash IVF, and Xero shares are dropping
- 2 ASX growth shares that experts love right now
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/UJE2oXS
Leave a Reply